Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Smoking cessation.

S I Rennard1, D M Daughton

  • 1University of Nebraska Medical Center, Omaha, NE 68198-5300, USA. srennard@mail.unmc.edu

Chest
|June 10, 2000
PubMed
Summary
This summary is machine-generated.

Quitting smoking is crucial for managing Chronic Obstructive Pulmonary Disease (COPD) symptoms and preventing its development. Pharmacologic and behavioral therapies help smokers overcome addiction, positively impacting COPD and overall health outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sphingosylphosphorylcholine induces α-smooth muscle actin expression in human lung fibroblasts and fibroblast-mediated gel contraction via S1P2 receptor and Rho/Rho-kinase pathway.

Prostaglandins & other lipid mediators·2014
Same author

PDE4: a novel target in the treatment of chronic obstructive pulmonary disease.

Clinical pharmacology and therapeutics·2011
Same author

Epithelial cells modulate genes associated with NF kappa B activation in co-cultured human macrophages.

Immunobiology·2011
Same author

Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic.

Clinical pharmacology and therapeutics·2011
Same author

Candidate genes for COPD in two large data sets.

The European respiratory journal·2010
Same author

Statins inhibit matrix metalloproteinase release from human lung fibroblasts.

The European respiratory journal·2009

Area of Science:

  • Pulmonology
  • Addiction Medicine
  • Public Health

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) is a significant health burden.
  • Cigarette smoking is the primary cause and exacerbating factor for COPD.
  • Effective interventions are needed to reduce smoking rates and mitigate COPD's impact.

Purpose of the Study:

  • To review pharmacologic and behavioral therapies for smoking cessation.
  • To highlight the importance of smoking cessation in COPD management.
  • To assess the impact of cessation strategies on COPD and other health outcomes.

Main Methods:

  • Literature review of pharmacologic therapies for smoking cessation.
  • Analysis of behavioral interventions aimed at smoking cessation.

Related Experiment Videos

  • Evaluation of the effectiveness of these strategies in reducing smoking addiction.

    • Main Results:

    • Smoking cessation is the most effective intervention for COPD symptom reduction and prevention.
    • Pharmacologic and behavioral therapies assist a significant minority of smokers in quitting.
    • Successful cessation positively influences COPD and broader health outcomes.

    Conclusions:

    • Smoking cessation is paramount in mitigating the burden of COPD.
    • Available therapies offer a viable pathway for smokers to overcome addiction.
    • These strategies have a substantial positive impact on COPD patients and public health.